Global Markets Direct Market Research Reports

TITLE Actions
Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Drugs in Development, 2021
Published in Oct 2021 | US $ 3500 Onwards | By Global Markets Direct

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Drugs in Development, 2021 Summary Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Metabotropic glutamate receptor 3 is a G protein-coupled recept...

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Drugs in Development, 2021
Published in Oct 2021 | US $ 3500 Onwards | By Global Markets Direct

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Drugs in Development, 2021 Summary According to the recently published report 'Metabotropic Glutamate Receptor 5 - Drugs In Development, 2021'; Metabotropic Glut...

Hepatitis C Virus Envelope Protein E2 - Drugs in Development, 2021
Published in Oct 2021 | US $ 3500 Onwards | By Global Markets Direct

Hepatitis C Virus Envelope Protein E2 - Drugs in Development, 2021 Summary Hepatitis C Virus Envelope Protein E2 pipeline Target constitutes close to 10 molecules. Out of which approximately 4 molecules are developed by comp...

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Drugs in Development, 2021
Published in Oct 2021 | US $ 3500 Onwards | By Global Markets Direct

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Drugs in Development, 2021 Summary Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth...

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021
Published in Oct 2021 | US $ 3500 Onwards | By Global Markets Direct

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021 Summary According to the recently published report 'Insulin Like Growth Factor I - Drugs In Development, 2021'; Insul...

Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Drugs in Development, 2021
Published in Oct 2021 | US $ 3500 Onwards | By Global Markets Direct

Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Drugs in Development, 2021 Summary Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) pipeline Target...

Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Drugs in Development, 2021
Published in Oct 2021 | US $ 3500 Onwards | By Global Markets Direct

Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Drugs in Development, 2021 Summary Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Soluble guanylyl cyclase (sGC) is the known receptor for nitric oxide. Binding of nitric oxid...

Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Drugs in Development, 2021
Published in Oct 2021 | US $ 3500 Onwards | By Global Markets Direct

Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Drugs in Development, 2021 Summary According to the recently published report 'Cyclin Dependent Kinase 2 - Drugs In D...

Sickle Cell Disease With Vaso-Occlusive Crisis (Hematology) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Sickle Cell Disease With Vaso-Occlusive Crisis (Hematology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sickle Cell Disease With Vaso-Occlusive Cri...

Parkinson's Disease (Central Nervous System) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2500 Onwards | By Global Markets Direct

Parkinson's Disease (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease - Drugs In Development, 2021, provides...

Amyotrophic Lateral Sclerosis (Central Nervous System) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2500 Onwards | By Global Markets Direct

Amyotrophic Lateral Sclerosis (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyotrophic Lateral Sclerosis - Drugs In Develop...

Insomnia (Central Nervous System) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Insomnia (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Insomnia - Drugs In Development, 2021, provides an overview of the In...

Cancer Pain (Central Nervous System) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Cancer Pain (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Drugs In Development, 2021, provides an overview of ...

Migraine (Central Nervous System) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Migraine (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine - Drugs In Development, 2021, provides an overview of the Mi...

Schizophrenia (Central Nervous System) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2500 Onwards | By Global Markets Direct

Schizophrenia (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Drugs In Development, 2021, provides an overview...

Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury - Drugs In Development, 2021, provides a...

Gastritis (Gastrointestinal) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Gastritis (Gastrointestinal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Drugs In Development, 2021, provides an overview of the Gastri...

Systemic Mastocytosis (Gastrointestinal) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Systemic Mastocytosis (Gastrointestinal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Mastocytosis - Drugs In Development, 2021, provides a...

Irritable Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Irritable Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Drugs In Development, 2021, prov...

Peritonitis (Gastrointestinal) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Peritonitis (Gastrointestinal) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Drugs In Development, 2021, provides an overview of the Pe...

We are on:

Need Help?

Buy Any Report Avail 20% Discount. Coupon Code: DEC20

Connect for special KNOWLEDGE STORE Deals
Subscription starts at $ 20K